Casdin Partners Master Fund, L.P., 10% Owner at Verve Therapeutics, Inc. (VERV), bought 2,107,311 shares at $19.00 ($20.9M) on 2021-06-21, disclosed to the SEC on 2021-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,007,311 | $0 | 0.0% |
| 2 | $19.00 | 1,100,000 | $20.9M | 100.0% |
| Total | $9.92 avg | 2,107,311 | $20.9M | 100% |
| Filing → |
| LAB | BUY | 2025-09-11 | $129K | — | Filing → |
| LAB | BUY | 2025-08-26 | $658K | — | Filing → |
| WGS | BUY | 2024-03-06 | $358K | — | Filing → |